Grifols (GIKLY) Profit After Tax (QoQ) (2010 - 2020)

Grifols (GIKLY) Profit After Tax (QoQ) (2010 - 2020) Analysis & Trends

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Eli Lilly	1,066.16 Bn	1,060.88 Bn	16.22 Bn
2	Johnson & Johnson	611.69 Bn	589.64 Bn	15.96 Bn
3	AbbVie	444.34 Bn	434.99 Bn	10.78 Bn
4	Astrazeneca	284.94 Bn	277.05 Bn	12.61 Bn
5	Merck	224.23 Bn	218.58 Bn	12.09 Bn
6	Amgen	195.12 Bn	183.08 Bn	5.87 Bn
7	Gilead Sciences	156.45 Bn	148.73 Bn	5.52 Bn
8	Pfizer	136.01 Bn	123.24 Bn	-1.21 Bn
9	Novartis Ag	113.45 Bn	113.67 Bn	-
10	Grifols	-	-	-

Historic Data

Download Data

Date	Value
Mar 31, 2020	-54.53%
Mar 31, 2019	-75.60%
Dec 31, 2018	-2.52%
Sep 30, 2018	161.51%
Jun 30, 2018	19.00%
Mar 31, 2018	-65.39%
Jun 30, 2017	10.84%
Mar 31, 2017	-5.09%
Dec 31, 2016	-4.90%
Sep 30, 2016	0.32%
Jun 30, 2016	-58.74%
Mar 31, 2016	-49.60%
Dec 31, 2015	386.14%
Sep 30, 2015	6.07%
Jun 30, 2015	1.60%
Mar 31, 2015	-80.40%
Dec 31, 2014	389.18%
Sep 30, 2014	106,176.95%
Jun 30, 2014	-99.91%
Mar 31, 2014	-75.79%